Trace Neuroscience Funding: $101M Raised, Series A (2024)
Trace Neuroscience is a Biotech company based in South San Francisco. It has raised $101M in total funding. Latest round: Series A.
Trace Neuroscience funding overview
Trace Neuroscience is a Biotech company based in South San Francisco. Trace Neuroscience has raised $101M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in November 2024. The round record for Trace Neuroscience runs through 2024; nothing later has been disclosed. Investors on record include Third Rock Ventures, Atlas Venture, GV, RA Capital Management. 4 distinct backers are named across the disclosed rounds.
Trace Neuroscience at a glance
Total raised
$101M
Latest round
Series A
Latest round date
November 2024
Industry
Biotech
Headquarters
South San Francisco
Notable investors
Third Rock Ventures, Atlas Venture, GV, RA Capital Management
Frequently asked about Trace Neuroscience funding
How much has Trace Neuroscience raised?
Trace Neuroscience has raised $101M in total disclosed funding across the rounds on record.
Who has invested in Trace Neuroscience?
Third Rock Ventures, Atlas Venture, GV, RA Capital Management are named among the investors backing Trace Neuroscience.
What was the latest Trace Neuroscience funding round?
The most recent disclosed round is a Series A, announced in November 2024.
Where is Trace Neuroscience based?
Trace Neuroscience is based in South San Francisco.
What sector does Trace Neuroscience operate in?
Trace Neuroscience is tracked under Biotech from South San Francisco, with $101M in disclosed funding.
When did Trace Neuroscience last raise?
The last disclosed Trace Neuroscience round closed in November 2024 at Series A.
Trace Neuroscience totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in South San Francisco below to benchmark round size and investor mix.
